|Day Low/High||76.59 / 77.47|
|52 Wk Low/High||55.80 / 85.07|
President Trump and HHS Secretary Alan Azer rolled out a plan to lower out of pocket costs for consumers when it comes to drug prices. Now comes the hard part.
It has been yet another long week on Wall Street. On Friday, investors are greeted with a mild Nvidia earnings related selloff. Be on the lookout for valuation-based tech stock downgrades in the week ahead.
Since taking office, President Trump has talked big on reining in drug prices, but the administration's lack of action leaves most expecting a May 11 speech that tastes like a nothing burger.
Walmart has elected to follow the Centers for Disease Control and Prevention guidelines for first time opioid patients, limiting prescriptions to no longer than a seven day supply.
It was Warren Buffett weekend as the famed investor held court with Berkshire Hathaway investors. Here are several observations for investors.
Added medications offer discounted treatment options for infection, migraine, overactive bladder, attention deficit, seizure and thyroid disorders; expands the program's offerings for heart disease and depression
Consistency in discipline will make the difference.
Cigna CEO David Cordani is game on in trying to shape the future of healthcare. He talks with TheStreet on where he thinks things are headed.
Cigna CEO David Cordani isn't ready to declare the future of healthcare will mean people go to retail stores to get all problems addressed.
Apple's earnings after the closing bell on Tuesday could set the tone for a meandering stock market. If the tech giant doesn't deliver in a big way, notably with its cash allocation plans, the broader market could easily tank.
Cigna CEO David Cordani talks to TheStreet on the progress of getting company's big deal for Express Scripts passed by regulators.
Cigna CEO David Cordani discusses the progress on closing the company's big deal for PBM Express Scripts.
Medication Reminders from Spouses are Not Appreciated While Technology Assistance Is
Doubleline's Gundlach Launches Facebook Short Campaign, Greenlight's Einhorn believes Assured Guarantee has massive losses "baked in" while Bill Ackman Protégé Scott Ferguson eyes a break up of Britain's WhitBread plc.
The company's underwriting margins and traditional health insurance business are key areas to watch, according to BMO Capital Markets' Matthew Borsch.
Paying for healthcare costs could be among your biggest concerns after retiring. Here's how the possible tie-in might change the way you access care.
A study of analyst recommendations at the major brokerages shows that Express Scripts Holding Co is the #85 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.
Better-than-expected earnings will help soothe market jitters in the second quarter.
A bullish divergence suggests a possible recovery in the near term.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer isn't expecting much action for shares of Cigna while it awaits its acquisition of Express Scripts to close.
David Cordani, president and CEO of health insurance provider Cigna, tells Jim Cramer about the deal for Express Scripts.
This market remains elevated, says Jim Cramer. It's perfectly reasonable to have some selling, but remember: Nobody makes money by panicking.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.